Summary
Around 1 in 7 (14%) women born in 1973–78 were estimated to have been diagnosed with endometriosis by age 44–49.
By age 31, 9.2% of women born in 1989–95 had been diagnosed with endometriosis compared with 6.9% of women born in 1973–78.
The rate of YLD for endometriosis has increased from 0.5 per 1,000 females in 2003 to 0.7 in 2024, after adjusting for differences in age structure over time.
Endometriosis remains the third leading cause of non-fatal disease burden among females due to reproductive and maternal conditions, after genital prolapse and polycystic ovarian syndrome.
An estimated $293 million was spent on endometriosis in the Australian health system in 2022–23.
Since 2013–14, total spending on endometriosis has more than doubled from $142 million to $293 million in 2022–23.
In 2022–23 there were 44,200 endometriosis-related hospitalisations.
This represents 335 hospitalisations per 100,000 females, up from 250 in 2012–13.
Hospitalisation rates doubled among females aged 20–24, from 325 hospitalisations per 100,000 females in 2012–13 to 650 per 100,000 in 2022–23.
Non-Indigenous Australians – 1.2 times the rate for First Nations women.
Females living in the least disadvantaged socioeconomic areas – 1.3 times the rate in the most disadvantaged areas.
Females living in Major cities of Australia – 1.5 times the rate for those living Remote and very remote areas.
Lasted 2 days or less, with 44% being same-day hospitalisations.
Were partly or fully funded by private health insurance (57%).
Took place in a private hospital (65%).
In 2023–24 there were 4,800 endometriosis-related ED presentations.
Where endometriosis was the main reason for attending the ED, the rate of presentations increased slightly from 29 per 100,000 females in 2018–19 to 32 per 100,000 in 2023–24.
Three-quarters (76%) of ED presentations were triaged as needing to be seen within 30 minutes or less.